10-K: Atomera Reports Wider FY25 Loss Amid R&D Boost, Secures $23.6M Funding

Atomera Incorporated reported a significant increase in net loss for fiscal year 2025, driven by higher operating expenses, while securing substantial post-period financing to extend its operational runway.

Summary

• Net loss increased to $20.2 million in 2025 from $18.4 million in 2024.
• Revenue decreased significantly to $65,000 in 2025 from $135,000 in 2024.
• Operating expenses rose to $20.9 million in 2025 from $19.3 million in 2024, primarily due to increased research and development.
• Cash used in operations increased to $14.9 million in 2025 from $13.2 million in 2024.
• Accumulated deficit reached $241.7 million as of December 31, 2025.
• Secured approximately $26.8 million in net proceeds from equity offerings in early 2026, extending capital runway for at least 24 months.
• A strategic marketing agreement with a global leader in chip fabrication technology was established in April 2025, targeting Gate-All-Around (GAA) and DRAM customers.
• ST Microelectronics put MST qualification on hold in October 2025 due to a process migration to 300mm wafers.
• Remediated a material weakness in internal control over financial reporting related to journal entry review and approval as of December 31, 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed filing with significant financial underperformance in FY25, highlighted by widening losses and revenue decline, and a notable setback with ST Microelectronics. However, the substantial capital raise post-period provides critical liquidity, and ongoing strategic partnerships and technology advancements offer future upside potential.

Positives

• Secured approximately $26.8 million in net proceeds from equity offerings in early 2026, significantly bolstering liquidity and extending the capital runway for at least 24 months.
• Entered into a strategic marketing agreement in April 2025 with a global leader in chip fabrication technology, aimed at accelerating MST adoption for next-generation GAA and DRAM technologies.
• Successfully remediated a previously identified material weakness in internal control over financial reporting as of December 31, 2025.
• Interest income increased by 20% to $931,000 in 2025 from $779,000 in 2024.
• Selling and marketing expenses decreased by 28% to $758,000 in 2025 from $1.1 million in 2024, primarily due to headcount reduction and lower travel expenses.
• Continued progress in developing MST technology for compound semiconductors like GaN-on-Silicon, showing enhanced crystalline quality and reduced defect density in preliminary experiments.
• One Joint Development Agreement (JDA) customer has advanced to Phase Four (Process Installation), having installed the MST film recipe and authorized internal fabrication.

Negatives

• Net loss widened to $20.2 million in 2025 from $18.4 million in 2024.
• Revenue declined significantly to $65,000 in 2025 from $135,000 in 2024.
• Cost of revenue increased to $321,000 in 2025 from $123,000 in 2024, leading to a negative gross margin of $256,000.
• Operating expenses increased by 8.3% to $20.9 million in 2025, driven by higher research and development costs ($12.3 million vs. $11.0 million in 2024) and general and administrative expenses ($7.8 million vs. $7.3 million in 2024).
• Cash used in operating activities increased to $14.9 million in 2025 from $13.2 million in 2024, indicating an accelerated cash burn.
• Accumulated deficit grew to $241.7 million as of December 31, 2025.
• ST Microelectronics put the qualification of MST on hold in October 2025, citing a migration of their targeted process to 300mm wafers, creating uncertainty regarding future commercialization with this customer.
• The company's business model is highly dependent on future royalties and license fees, which are inherently risky and subject to customer adoption and market conditions.
• The market price of common stock has shown significant volatility, ranging from $1.89 to $17.55 between January 1, 2025, and February 20, 2026.

Risks

• Limited revenue generation to date makes it difficult for potential investors to evaluate the business, viability of the licensing model, or prospective operations.
• History of significant operating losses and anticipated continued losses for at least the near term, with an accumulated deficit of approximately $241.7 million as of December 31, 2025.
• Uncertainty regarding the advancement of existing commercial license agreements, integration license agreements, and joint development agreements to further licensing stages or royalty-based distribution.
• ST Microelectronics put MST qualification on hold in October 2025, with no assurance on when or if they will re-commence, or if MST will deliver the performance, power, or other requirements that ST or other customers seek for their products.
• Lengthy and costly product qualification and licensing cycles (estimated 18 to 36 months or longer from initial engagement to product incorporation).
• Qualification of MST technology requires timely access to potential customers' manufacturing tools and facilities, as well as leased tools, which may be subject to delays due to tight industry capacity or equipment downtime.
• Long-term success is dependent on a royalty-based business model, which is inherently risky due to factors like adoption rates, customer willingness to agree to an ongoing royalty model, successful marketing of MST-enabled products, the length of the design cycle, demand for products, and market cyclicality.
• Need for additional financing to execute the business plan and fund operations, which may not be available on reasonable terms or at all, potentially leading to curtailment of R&D or cost reductions.
• Unfavorable geopolitical and macroeconomic developments (e.g., inflation, conflicts, increased export controls, national self-sufficiency efforts in the semiconductor supply chain) could adversely affect business, financial condition, or results of operations.
• Internal computer systems or those of collaborators/contractors may fail or suffer security breaches, potentially disrupting development programs, leading to loss of proprietary information, liability, and harm to competitive position.
• Revenue may be concentrated in a few customers, and the loss of any of these customers or non-payment could materially adversely affect revenues.
• Inability to manage future expansion effectively during a rapid growth phase could strain managerial, administrative, technical, operational, and financial resources.
• Difficulty verifying royalty amounts owed under licensing agreements, potentially leading to lost revenues.
• Risk of product liability or other claims if integrated circuits incorporating MST technology are used in defective products.
• Failure to protect and enforce intellectual property rights (patents, trade secrets, confidential information) could weaken competitive position, reduce operating results, and increase litigation risk.
• A court invalidation or limitation of key patents could significantly harm the business by reducing new licenses and existing royalty payments.
• Potential involvement in material legal proceedings to enforce or protect intellectual property rights, which could be costly, divert resources, and harm customer relationships.
• Risk that MST technologies may infringe on the intellectual property rights of others, leading to costly disputes, injunctions, or disruptions.
• Market price of common stock is subject to wide fluctuations and volatility, potentially leading to substantial losses for investors.
• No history or immediate plans to pay dividends.
• Charter documents and Delaware law may inhibit a takeover that stockholders consider favorable.
• Bylaws designate the Court of Chancery of the State of Delaware as the sole and exclusive forum for certain litigation, potentially limiting stockholders' ability to obtain a favorable judicial forum.
• Board of directors may issue blank check preferred stock, which could affect voting rights of common stockholders and deter or delay attempts to obtain control.

Future Outlook

The company anticipates continued operating losses for at least the near term. It believes its available working capital, including proceeds from the February 2026 offering, is sufficient to fund current business plans and obligations for at least the next 24 months. Future capital requirements depend on successful MST commercialization, competing technological and market developments, and the need to enter into collaborations with other companies or acquire technologies to enhance or complement current offerings. The company expects increased research and development expenses in the next 12 months. There can be no assurance that MST will deliver the performance, power, or cost reduction customers seek, or that the integration of its technology with customers' manufacturing processes will be successful in high volume, or that licensees will proceed to commercial production.

Management Comments

• "We believe that MST can be widely incorporated into the most common types of semiconductor products, including analog, logic, optical and memory integrated circuits."
• "Our principal business objective is to enter into commercial license agreements that enable our customers to manufacture and sell MST-enabled products, generating license revenues and ongoing royalties."
• "We believe MST has the potential to overcome the key challenges found in the implementation of next-generation nano-scale semiconductor devices incorporating CMOS type transistors, namely enhancing drive current, reducing leakage and reducing variability."
• "We believe MST can offer a cost-effective solution to these tradeoffs by serving as a buffer layer between different materials, such as between GaN and a silicon wafer substrate."
• "We believe that MST will provide a lower cost of production due to our technology’s potential to reduce die size and/or improve yield while leveraging existing manufacturing tools, thereby providing chip makers with increased performance at all process nodes with significantly fewer disruptions to manufacturing processes and less incremental cost than other advanced technologies."
• "We believe that our success is dependent upon the adoption of our MST technology through to commercial production by at least one IDM, foundry, or fabless semiconductor manufacturer."
• "We believe that our relationships with leading OEMs, especially the collaboration under our strategic marketing agreement, will simultaneously drive additional sales of their capital equipment and encourage more customers to adopt MST."
• "We believe this modeling capability has shortened the time required for us to engage with new potential customers and should ultimately lead to a faster decision process by the customer regarding licensing MST."
• "While management will endeavor to generate positive cash flows from the commercialization of our MST technology, there can be no assurance that we will be successful in doing so."
• "Management has concluded that our internal control over financial reporting was effective, at the reasonable assurance level as of December 31, 2025."

Industry Context

StockSavvy.ai notes that Atomera operates within a rapidly expanding global semiconductor market, projected to reach $755 billion in 2025, largely driven by AI workloads. The industry faces critical challenges in power delivery, thermal management, and the need for advanced semiconductors offering improved compute performance per watt. Atomera's Mears Silicon Technology (MST), designed to enhance transistor speed, reliability, and power efficiency, directly addresses these industry-wide demands, particularly for advanced logic (Gate-All-Around) and DRAM, which are key beneficiaries of AI trends. The company's focus on additive, low-cost solutions compatible with existing manufacturing processes positions it to capitalize on the industry's shift towards new engineered materials and open innovation models to manage R&D costs and accelerate time-to-market. The strategic marketing agreement with a leading chip fabrication technology vendor aligns with the industry's collaborative approach to integrating externally developed IP.

Comparison to Industry Standards

• MST-enabled enhancements are approximately equivalent to one-half to a full node of improvement, which can extend the productive life of capital equipment and wafer fabrication facilities, offering a cost-effective alternative to full node transitions.
• MST compares favorably to other CMOS performance enhancement alternatives and is compatible with existing technologies such as strained silicon and High-K/Metal Gate.
• The company believes MST offers industry-leading on-resistance at comparable or improved breakdown voltage and reliability metrics for power devices (MST-SP, MST-SPX), enabling reduced footprint compared to conventional solutions.
• Preliminary results from collaboration with Texas State University indicate MST substrates enable improvements in GaN material quality over standard Si substrates, addressing a key challenge in compound semiconductors.
• Historically, new material technologies for the semiconductor industry have taken 10-20 years from conceptualization to volume production; Atomera's MST has followed a similar trajectory, suggesting it is reaching a mature stage for adoption.
• The company is not aware of another technology being offered in the market which provides the same technical benefits as MST, suggesting a unique competitive position, though internal customer solutions or other third-party offerings may provide some similar benefits.

Corporate Governance

Legal Proceedings

• As of December 31, 2025, and through the date of the Annual Report, there are no pending material legal proceedings to which the company or its properties are subject.

Related Party Transactions

• On April 28, 2024, the company sold 2,247 shares of its common stock to the Chief Executive Officer, Scott Bibaud, at a price of $4.45 per share, for total proceeds of approximately $10,000.

Stakeholder Impact

• Shareholders face potential for dilution from ongoing and future equity offerings, but also benefit from an extended capital runway. Volatility in stock price is a significant risk, and anti-takeover provisions may limit opportunities for control premiums.
• Employees benefit from equity incentive plans designed to attract, retain, and reward personnel, aligning compensation with business objectives and shareholder value. There was a reduction in headcount in selling and marketing in 2025.
• Customers have the potential for enhanced product performance (speed, reliability, power efficiency) and lower production costs through MST technology. However, delays in qualification and the uncertainty with ST Microelectronics highlight risks in technology adoption.
• Creditors face ongoing financial risk due to the company's recurring operating losses and negative cash flows from operations, though recent capital raises improve short-term liquidity.
• Suppliers and partners, such as Synopsys and the global leader in chip fabrication technology, are engaged in strategic collaborations that could drive future business and technology adoption.

Next Steps

• Continue efforts to advance licensing arrangements with the RF licensee and foundry licensee to R&D and HVM licenses and to shipment of royalty-bearing products.
• Capitalize on the achievement of technical milestones in the first JDA to enter into distribution and royalty agreements with business units of that customer.
• Meet technical targets and milestones in the JDA with the second JDA customer.
• Convert licensees of MSTcad software to licenses of MST technology under commercial license agreements.
• Continue to refine MSTcad by calibrating models against measured silicon results and release regular updates.
• Develop and test GaN-on-Silicon technology with first customers.
• Continue research to explore how MST can be used to improve materials and disrupt markets.
• File a definitive proxy statement pursuant to Regulation 14A within 120 days after December 31, 2025.
• Increase research and development expenses in the next 12 months.

Key Dates

Recommendation

Atomera's financial performance in FY25, marked by widening losses and declining revenue, is concerning and reflects the challenges of commercializing a deep-tech semiconductor IP. The setback with ST Microelectronics further underscores the long and uncertain path to high-volume adoption. However, the substantial capital raise of $26.8 million post-period provides a crucial 24-month runway, alleviating immediate liquidity concerns. The strategic marketing agreement and ongoing R&D into advanced applications like GaN-on-Silicon offer long-term potential. Given the early stage of commercialization, the high-risk/high-reward nature of the technology, and the recent capital infusion, a "hold" recommendation is appropriate. Investors should monitor progress on customer qualifications and royalty-generating agreements, as well as the effective deployment of the newly raised capital, before considering further investment.

Keywords

semiconductor technology, Mears Silicon Technology, MST, silicon wafers, integrated circuits, licensing, royalties, CMOS, GaN-on-Silicon, power devices, RFSOI, GAA transistors, DRAM, TCAD software, Synopsys, intellectual property, chip fabrication, financial reporting, SEC filing, 10-K, equity offering, cash burn, operating losses, semiconductor industry, AI, advanced materials